Neptune Wellness Solutions Inc.
Neptune Wellness Solutions Inc. (NEPT): 5 pipeline candidates · ~1 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
0.9 months
D/E -2.41 · 0% dilution
Lead: Approved
5 candidates
N/A
N/A
A transparent, data-derived signal for Neptune Wellness Solutions Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
$1.2M
Quarterly Burn
$18.7M
Runway
0.9 mo
Revenue
$7.6M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
Frequently asked questions
How many drug candidates are in Neptune Wellness Solutions Inc.'s pipeline?
Neptune Wellness Solutions Inc. (NEPT) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Neptune Wellness Solutions Inc.'s lead drug candidate?
Neptune Wellness Solutions Inc.'s most advanced tracked candidate is maxsimil (Approved) for Nutraceutical/Nutritional supplement for digestion and absorption of fat-soluble and nutritional ingredients.
What is Neptune Wellness Solutions Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Neptune Wellness Solutions Inc. has approximately 0.9 months of cash runway.
Get the full picture on Neptune Wellness Solutions Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.